Andrew J. Davies
Southampton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.
Journal: Blood advances
Published: January 21, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.
Journal: Haematologica
Published: January 21, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.
Journal: Blood advances
Published: January 21, 2026
High-grade B-cell lymphomas: high difficulties to diagnose and treat?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 02, 2025
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.
Journal: HemaSphere
Published: September 05, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 29, 2025
The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma.
Journal: Blood
Published: March 14, 2025
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial.
Journal: Lancet (London, England)
Published: February 18, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline.
Journal: British journal of haematology
Published: February 07, 2025
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 30, 2024
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia.
Journal: Discover oncology
Published: September 20, 2024
Last Updated: 09/26/2026